The annual Biotech Industry Organization (BIO) show is known for being an event where big deals are developed and sometimes consummated. This year's show may be remembered for the shameless courtship between Big Pharma companies and biotech innovators, reports Fortune's David Ewing Duncan. GSK, for example, brought in a team of 35 and held some 300 meetings, Duncan notes.
For the full article, read here.